# Aduro Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aduro-biotech

- Industry: Biotechnology
- Headquarters: Berkeley, US
- Website: www.adurobiotech.com
- Total disclosed funding: $111M
- Latest round: Series D (Dec 29, 2014)
- Investors on record: 8

## About

Founded in 2000, based in Berkeley, California, Aduro Biotech Inc. operates as a biotechnology company that develops and provides immunotherapeutics to treat patients with breast, prostate, colorectal, lung, pancreas, ovarian, head, and neck cancers.

## Funding rounds

- Series D, Dec 29, 2014, $51M — OrbiMed Advisors, Franklin Street Advisors (Delete), 5Y Capital, Janus Henderson Investors, Jennison Associates, Foresite Capital, Clough Capital Partners
- Series C, Jun 12, 2014, $41M — Johnson & Johnson Innovation, 5Y Capital
- Series B, Apr 20, 2011, $19M — 5Y Capital

## Investors

- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series B, Series C, Series D
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series C
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series D
- Franklin Street Advisors (Delete) — Series D
- Janus Henderson Investors — Series D
- Jennison Associates — Series D
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series D
- Clough Capital Partners — Series D